Indicators

Latest News about RGNX

Recent news which mentions RGNX

< Previous 1 2 3 4 5 Next >

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Expert Ratings For Regenxbio

January 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021

December 15, 2021

RegenXbio's Duchenne Gene Therapy Secures FDA Orphan Drug Tag

November 22, 2021

70 Biggest Movers From Yesterday

November 16, 2021

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares

November 12, 2021

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More

November 08, 2021

Barron's Latest Picks And Pans: Alleghany, Blade Air Mobility, Gene Therapy Picks And More

November 06, 2021

REGENXBIO inc (RGNX) Q3 2021 Earnings Call Transcript

November 03, 2021

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US

November 02, 2021

Earnings Scheduled For November 2, 2021

November 02, 2021

Earnings Outlook For Regenxbio

November 01, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

3 High-Yield Dividend Stocks I'm Not Selling Anytime Soon

October 18, 2021

Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial

October 11, 2021

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage

October 10, 2021

44 Biggest Movers From Yesterday

October 05, 2021

12 Health Care Stocks Moving In Monday's Intraday Session

October 04, 2021

30 Stocks Moving In Monday's Mid-Day Session

October 04, 2021

The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More

October 03, 2021

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

October 01, 2021

Could AbbVie's New Collaboration Be a Blockbuster?

September 27, 2021

Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal

September 25, 2021

Looking Into Regenxbio's Return On Capital Employed

September 15, 2021

72 Biggest Movers From Yesterday

September 14, 2021

Why Regenxbio Stock Is Way Up Today

September 13, 2021

12 Health Care Stocks Moving In Monday's Intraday Session

September 13, 2021

45 Stocks Moving In Monday's Mid-Day Session

September 13, 2021

Why Regenxbio Shares Are Trading Higher Today

September 13, 2021

AbbVie, RegenXBio Ink $1.75B Retinal Gene Therapy Collaboration

September 13, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.